FDA Recall
🇺🇸 United States
Terminated
2026 recordClass II
Wawa Beverage Company
- Product
- Wawa Cookies & Cream Milk 16 oz (Pint), Plastic bottle Store…
- Reason
- Foreign plastic material discovered on fill line.
- Published
- March 25, 2026
- Distribution
- The recalled product was distributed to…
View recall →
FDA Recall
🇺🇸 United States
Terminated
2026 recordClass II
Wawa Beverage Company
- Product
- Wawa Double Dutch Chocolate Milk ,16 oz (Pint) Plastic bottl…
- Reason
- Foreign plastic material discovered on fill line.
- Published
- March 25, 2026
- Distribution
- The recalled product was distributed to…
View recall →
FDA Recall
🇺🇸 United States
Terminated
2026 recordClass II
Wawa Beverage Company
- Product
- Wawa Reduced Fat Milk 2% 16 oz (Pint)
- Reason
- Foreign plastic material discovered on fill line.
- Published
- March 25, 2026
- Distribution
- The recalled product was distributed to…
View recall →
FDA Recall
🇺🇸 United States
Ongoing
2026 recordClass III
Winder Laboratories, LLC
- Product
- Multivitamin with Fluoride Chewable Tablets Grape Flavor Rx…
- Reason
- Subpotent. During an FDA inspection it was discovered that the product was subpotent for Vitamin D.
- Published
- March 25, 2026
- Distribution
- Product was shipped to the following sta…
View recall →
FDA Recall
Ongoing
2026 recordClass II
Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7
by Zydus Pharmaceuticals (USA) Inc
- Reason
- Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
- Published
- March 18, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Ongoing
2026 recordClass II
Palmetto Gourmet Foods Inc.
- Product
- VEGETARIAN CHICKEN FLAVOR RAMEN Express Net wt 3oz (85g) Ing…
- Reason
- Product contains undeclared Yellow #5
- Published
- March 18, 2026
- Distribution
- Product was shipped to the following sta…
View recall →
FDA Recall
🇺🇸 United States
Ongoing
2026 recordClass II
Palmetto Gourmet Foods Inc.
- Product
- VEGETARIAN CHICKEN FLAVOR RAMEN Express Net wt 3oz (85g) Ing…
- Reason
- Product contains undeclared Yellow #5
- Published
- March 18, 2026
- Distribution
- Product was shipped to the following sta…
View recall →
FDA Recall
🇺🇸 United States
Ongoing
2026 recordClass I
Ambrosia Brands LLC
- Product
- Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 cap…
- Reason
- Product may be contaminated with Salmonella
- Published
- March 18, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Ongoing
2026 recordClass III
Tipp Distributors, Inc. dba Novamex
- Product
- C2O Coconut Water with Pulp (17.5 oz) 15 Pack UPC: 8-50274-0…
- Reason
- The outer cardboard box for the canned coconut water has the incorrect Nutrition Facts Panel and Ingredient List, which does not include added sugar (5g per 17.5oz can), while the primary packaging (the can) has the correct Nutrition Facts Panel and Ingredient List.
- Published
- March 18, 2026
- Distribution
- Multiple states
View recall →
FDA Recall
Ongoing
2026 recordClass II
Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.
by MYLAN PHARMACEUTICALS INC
- Reason
- Failed Dissolution Specifications
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass I
Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0
by Mohamed Hagar
- Reason
- Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.
by Radnostix
- Reason
- Presence of Particulate Matter: Due to production issues
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass I
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
by ANTHONY TRINH, 123Herbals LLC
- Reason
- Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.
by HTO Nevada Inc. dba Kirkman
- Reason
- Stability Data Does Not Support Expiry Date.
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014.
by HTO Nevada Inc. dba Kirkman
- Reason
- Stability Data Does Not Support Expiry Date.
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016.
by HTO Nevada Inc. dba Kirkman
- Reason
- Stability Data Does Not Support Expiry Date.
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.
by Rising Pharma Holding, Inc.
- Reason
- Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
by The Harvard Drug Group LLC
- Reason
- Defective container; inadequately sealed blister packaging.
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass III
Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each), NDC 69097-032-74; Inner carton: 28 capsules (4 blisters of 7 capsules), NDC 69097-032-56; Foil blister: NDC 69097-032-17
by Cipla USA, Inc.
- Reason
- Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass III
Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each) NDC 69097-031-74; Inner carton: 28 capsules (4 blisters of 7 capsules) NDC 69097-031-56; Foil blister: NDC 69097-031-17
by Cipla USA, Inc.
- Reason
- Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
- Published
- March 11, 2026
- Distribution
- Nationwide
View recall →
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions.
Read the full medical disclaimer.